Abstract
Obesity is commonly associated with type 2 diabetes and vascular disease. Changes in body composition in the obese state lead to a dysregulation of secretion of adipocyte-secreted hormones known as adipokines. Adipokines such as leptin and adiponectin are known to be involved in many physiological and pathological processes. Current knowledge suggests that adipokines provide potential therapeutic targets against type 2 diabetes and vascular disease.
| Original language | English |
|---|---|
| Pages (from-to) | 249-254 |
| Number of pages | 6 |
| Journal | British Journal of Diabetes and Vascular Disease |
| Volume | 12 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Sept 2012 |
Keywords
- adipokines
- leptin
- adiponectin
- vascular disease
- obesity
- type 2 diabetes